Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regulation of laboratory-developed tests and in-house in vitro diagnostic medical devices in the United States and the European Union-a comparative overview.

ESMO open·2025
Same author

Advancing Lung Cancer Staging: Integrating IASLC Recommendations and Bioinformatics to Delineate Tumor Origins.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2025
Same author

Erratum to "Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project": [Annals of Oncology 32 (2021) 1626-1636].

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

The German Network for Personalized Medicine to enhance patient care and translational research.

Nature medicine·2023
Same author

Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD).

NPJ precision oncology·2022
Same author

Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Related Experiment Video

Updated: Mar 15, 2026

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

17.1K

[Metabolome analysis of solid tumors].

J Budczies1

  • 1Institut für Pathologie, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Deutschland. jan.budczies@charite.de.

Der Pathologe
|September 18, 2016
PubMed
Summary

Metabolomics analysis using GC-TOFMS in tumor tissues reveals metabolites as viable biomarkers. These findings offer new clinical applications for cancer diagnostics and treatment strategies.

Area of Science:

  • Biochemistry
  • Oncology
  • Analytical Chemistry

Background:

  • Metabolomics has emerged as a high-throughput technology alongside genomics, transcriptomics, and proteomics.
  • Analyzing central metabolism in tumor tissues is crucial for understanding cancer biology.

Purpose of the Study:

  • To evaluate metabolomics as a reliable high-throughput technology for analyzing tumor metabolism.
  • To demonstrate the utility of metabolites as biomarkers for clinical applications in oncology.

Main Methods:

  • Gas chromatography coupled with time-of-flight mass spectrometry (GC-TOFMS) for metabolome analysis.
  • Bioinformatics tools, including PROFILE clustering, for integrated data interpretation within metabolic pathways.

Main Results:

Keywords:
Beta-alanineGlutamic acidGlutaminase inhibitorsMetabolomicsNeoplasms

More Related Videos

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis
06:48

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis

Published on: May 31, 2020

6.4K
Extraction of Aqueous Metabolites from Cultured Adherent Cells for Metabolomic Analysis by Capillary Electrophoresis-Mass Spectrometry
11:39

Extraction of Aqueous Metabolites from Cultured Adherent Cells for Metabolomic Analysis by Capillary Electrophoresis-Mass Spectrometry

Published on: June 9, 2019

9.8K

Related Experiment Videos

Last Updated: Mar 15, 2026

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

17.1K
On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis
06:48

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis

Published on: May 31, 2020

6.4K
Extraction of Aqueous Metabolites from Cultured Adherent Cells for Metabolomic Analysis by Capillary Electrophoresis-Mass Spectrometry
11:39

Extraction of Aqueous Metabolites from Cultured Adherent Cells for Metabolomic Analysis by Capillary Electrophoresis-Mass Spectrometry

Published on: June 9, 2019

9.8K
  • Metabolome analysis of three solid tumor types was performed.
  • Metabolites were identified as suitable biomarkers with potential for clinical translation.
  • The study supports the role of metabolomics in cancer research and diagnostics.

Conclusions:

  • Metabolomics, particularly using GC-TOFMS, is a powerful tool for cancer research.
  • Identified metabolites serve as promising biomarkers for clinical applications.
  • This technology offers diverse options for translating research findings into clinical practice.